Ledger.Open graph →
SEC Form D · filed July 2, 2015

Beta Cat Pharmaceuticals, Inc

Offering
$3.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Houston, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Sunil P. Sharma · Houston, TXExec · DirectorKenneth P. Carter · Houston, TXDirectorJoseph P. Cunningham · Houston, TXDirectorJonathan P. Northrup · Houston, TXExec · DirectorAlain P. Cappeluti · Houston, TXExecStephen P. Horrigan · Houston, TXExecCasey P. Cunningham · Houston, TXExecSunil P. Sharma · Houston, TXExec · DirectorKenneth P. Carter · Houston, TXDirectorJoseph P. Cunningham · Houston, TXDirectorJonathan P. Northrup · Houston, TXExec · DirectorAlain P. Cappeluti · Houston, TXExecStephen P. Horrigan · Houston, TXExecCasey P. Cunningham · Houston, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗